These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34406082)

  • 1. Identification of Risk Factors for Multidrug-Resistant Organisms in Community-Acquired Bacterial Pneumonia at a Community Hospital.
    Covington EW; Rufe A
    J Pharm Pract; 2023 Apr; 36(2):303-308. PubMed ID: 34406082
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia.
    Gross AE; Van Schooneveld TC; Olsen KM; Rupp ME; Bui TH; Forsung E; Kalil AC
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5262-8. PubMed ID: 24957843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of drug-resistant pathogens in community-acquired pneumonia at a safety net hospital.
    Ding H; Mang NS; Loomis J; Ortwine JK; Wei W; O'Connell EJ; Shah NJ; Prokesch BC
    Microbiol Spectr; 2024 Aug; 12(8):e0079224. PubMed ID: 39012119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Risk Factors of Multidrug-Resistant Organisms in Hospitalized Patients with Community-Acquired Pneumonia in Dr. Soetomo Hospital Surabaya, Indonesia.
    Soedarsono S; Widyaningsih PD; Mertaniasih NM
    Acta Med Indones; 2021 Apr; 53(2):169-176. PubMed ID: 34251345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-acquired pneumonia with risk for drug-resistant pathogens.
    Fleming V; Buck B; Nix N; Kumar P; Southwood R
    South Med J; 2013 Mar; 106(3):209-16. PubMed ID: 23462490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in Empiric Coverage Versus Detection of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in Hospitalizations for Community-Onset Pneumonia Across 128 US Veterans Affairs Medical Centers.
    Jones BE; Brown KA; Jones MM; Huttner BD; Greene T; Sauer BC; Madaras-Kelly K; Rubin MA; Bidwell Goetz M; Samore MH
    Infect Control Hosp Epidemiol; 2017 Aug; 38(8):937-944. PubMed ID: 28633678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.
    Cillóniz C; Gabarrús A; Ferrer M; Puig de la Bellacasa J; Rinaudo M; Mensa J; Niederman MS; Torres A
    Chest; 2016 Aug; 150(2):415-25. PubMed ID: 27060725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia.
    Prina E; Ranzani OT; Polverino E; Cillóniz C; Ferrer M; Fernandez L; Puig de la Bellacasa J; Menéndez R; Mensa J; Torres A
    Ann Am Thorac Soc; 2015 Feb; 12(2):153-60. PubMed ID: 25521229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms.
    Martin-Loeches I; Torres A; Rinaudo M; Terraneo S; de Rosa F; Ramirez P; Diaz E; Fernández-Barat L; Li Bassi GL; Ferrer M
    J Infect; 2015 Mar; 70(3):213-22. PubMed ID: 25445887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of multidrug resistant organism acquisition in an adult specialist burns service: a retrospective review.
    Cleland H; Tracy LM; Padiglione A; Stewardson AJ
    Antimicrob Resist Infect Control; 2022 Jun; 11(1):82. PubMed ID: 35698209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance, and clinical outcomes.
    Hyun H; Song JY; Yoon JG; Seong H; Noh JY; Cheong HJ; Kim WJ
    PLoS One; 2022; 17(6):e0270261. PubMed ID: 35767562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
    Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
    Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empiric therapy directed against MRSA in patients admitted to the intensive care unit does not improve outcomes in community-acquired pneumonia.
    Griffin AT; Peyrani P; Wiemken TL; Ramirez JA; Arnold FW
    Infection; 2013 Apr; 41(2):517-23. PubMed ID: 23132663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Impact of Hospital-acquired Pneumonia Guidelines on Empiric Antibiotics. An Evaluation of 113 Veterans Affairs Medical Centers.
    Bostwick AD; Jones BE; Paine R; Goetz MB; Samore M; Jones M
    Ann Am Thorac Soc; 2019 Nov; 16(11):1392-1398. PubMed ID: 31385720
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk Factor Evaluation for Methicillin-Resistant
    Lewis PO
    Ann Pharmacother; 2021 Jan; 55(1):36-43. PubMed ID: 32545992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
    Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
    Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.
    Webb BJ; Dascomb K; Stenehjem E; Dean N
    Respir Med; 2015 Jan; 109(1):1-10. PubMed ID: 25468412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with bacteraemia due to multidrug-resistant organisms among bacteraemic patients with multidrug-resistant organism carriage: a case control study.
    Mascitti H; Duran C; Nemo EM; Bouchand F; Câlin R; Descatha A; Gaillard JL; Lawrence C; Davido B; Barbier F; Dinh A
    Antimicrob Resist Infect Control; 2018; 7():116. PubMed ID: 30288256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying patients at high risk for multidrug-resistant organisms after hospitalization abroad.
    Bopp TC; Marchesi M; Zihlmann R; Sax H; Wolfensberger A
    Infect Control Hosp Epidemiol; 2023 Aug; 44(8):1281-1288. PubMed ID: 36912341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A multicentric study on clinical characteristics and antibiotic sensitivity in children with methicillin-resistant
    Wu X; Yu H; He LY; Wang CQ; Xu HM; Zhao RQ; Jing CM; Chen YH; Chen J; Deng JK; Shi J; Lin AW; Li L; Deng HL; Cai HJ; Chen YP; Wen ZW; Yang JH; Zhang T; Xiao FF; Cao Q; Huang WC; Hao JH; Zhang CH; Huang YY; Ji XF
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):628-634. PubMed ID: 32842382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.